Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  1987-03-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-291X(87)90346-9PMID 3494449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods of Enzymatic Analysis

  2019cited by this paper
• Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

  1986cited by this paper
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+.

  1986cited by this paper
• Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys

  1986cited by this paper
• Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

  1986cited by this paper
• Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

  1986cited by this paper
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes.

  1986cited by this paper
• Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism.

  1986cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

  1985cited by this paper
• Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?

  1985cited by this paper
• Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.

  1984cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper
• 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.

  1984cited by this paper
• On the isolation of mitochondria with high respiratory control from rat brain.

  1966cited by this paper
• Methods in Enzymology , Vol

  1966cited by this paper

• Mitochondrial dysfunction in Parkinson’s disease

  2024influential citation
• Pathological mechanisms and treatment of sporadic Parkinson’s disease: past, present, and future

  2024cites this paper
• The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.

  2021cites this paper
• Mild MPP+ exposure-induced glucose starvation enhances autophagosome synthesis and impairs its degradation

  2017cites this paper
• Computer-aided Drug Design Applied to Parkinson Targets

  2017cites this paper
• Apoptosis and Autophagy

  2017cites this paper
• Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease

  2015cites this paper
• Melatonin in Parkinson’s Disease

  2014cites this paper
• Acetyl-L-Carnitine in Parkinson’s Disease

  2012cites this paper
• Mitochondria and Parkinson's Disease

  2012cites this paper
• Parkinson's syndrome and Parkinson's disease in mitochondrial disorders

  2011cites this paper
• Do Somatic Mitochondrial DNA Mutations Contribute to Parkinson's Disease?

  2011cites this paper
• Loss of striatal dopaminergic terminals during the early stage in response to MPTP injection in C57BL/6 mice.

  2011cites this paper
• Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

  2010cites this paper
• Progress in the pathogenesis and genetics of Parkinson's disease

  2008cites this paper
• Anaerobic Glycolysis Protection against 1-Methy-4-Phenylpyridinium (MPP+) Toxicity in C6 Glioma Cells

  2007cites this paper
• Etiology and pathogenesis of Parkinson^|^apos;s disease

  2006cites this paper
• 1H MRS identifies lactate rise in the striatum of MPTP‐treated C57BL/6 mice

  2006cites this paper
• H MRS identifies lactate rise in the striatum of MPTP-treated C57BL/6 mice.

  2006cites this paper
• Temporal evolution of mouse striatal gene expression following MPTP injury.

  2005cites this paper
• Etablierung eines Tiermodells der Parkinson-Krankheit auf der Grundlage von mitochondrialer Komplex-I Hemmung

  2004cites this paper
• [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

  2004cites this paper
• Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson's Disease

  2004cites this paper
• Parkinson's Disease: Mechanisms of Neuronal Death

  2004cites this paper
• MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease

  2004cites this paper
• Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

  2004cites this paper
• Possible Mechanisms Underlying the Protective Action of Immunosuppressants Against Parkinson’s Disease

  2003cites this paper
• Vitamin E therapy in Parkinson's disease.

  2003cites this paper
• MPP+ analogs acting on mitochondria and inducing neuro-degeneration.

  2003cites this paper
• 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum.

  2003cites this paper
• Neuroprotective Ganglioside Derivatives

  2003cites this paper
• Mitochondrial Mutations in Parkinson's Disease and Dystonias

  2003cites this paper
• Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat.

  2002cites this paper
• Specific up‐regulation of GADD153/CHOP in 1‐methyl‐4‐phenyl‐pyridinium‐treated SH‐SY5Y cells

  2002cites this paper
• Parkinson's disease.

  2002cites this paper
• Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders?

  2001cites this paper
• Influence of glutathione on the oxidation chemistry of 5-S-cysteinyldopamine: potentially neuroprotective reactions of relevance to Parkinson's disease

  2001cites this paper
• Neurochemical findings in the MPTP model of Parkinson's disease

  2001cites this paper
• Oxidative metabolites of 5-S-cysteinyldopamine inhibit the α-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease

  2000influential citation
• Parkinson's Disease as Multifactorial Oxidative Neurodegeneration: Implications

  2000cites this paper
• Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: possible implications for neurodegenerative brain disorders.

  2000cites this paper
• Role of quinones in toxicology.

  2000cites this paper
• Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling.

  2000cites this paper
• Apoptosis by an Endogenous Neurotoxin, N-Methyl(R)Salsolinol: Relevance to Parkinson’s Disease

  2000cites this paper
• Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration.

  2000cites this paper
• The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.

  2000cites this paper
• Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management.

  2000cites this paper
• Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells.

  2000cites this paper
• Potential Roles of Accelerated Dopamine Oxidation, Altered Glutathione Metabolism, 5-S-Cysteinyl-Dopamine and its Oxidative Metabolites in the Pathogenesis of Parkinson’s Disease

  2000cites this paper
• Invited Review Role of Quinones in Toxicology

  2000cites this paper
• Nigrostriatal dopaminergic neurotoxicity of L-cysteine after stereotaxic administration into the substantia nigra of rats: Potential implications for MPTP-induced neurotoxicity and parkinson’s disease

  2000cites this paper
• Glucose protection from MPP+-induced apoptosis depends on mitochondrial membrane potential and ATP synthase.

  1999cites this paper
• Mitochondrial permeability in neuronal death: possible relevance to the pathogenesis of Parkinson's disease.

  1999cites this paper
• Neuroprotective therapies.

  1999cites this paper
• Inhibitors of Mitochondrial Respiration, Iron (II), and Hydroxyl Radical Evoke Release and Extracellular Hydrolysis of Glutathione in Rat Striatum and Substantia Nigra

  1999cites this paper
• Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

  1998cites this paper
• Insecticide-Mediated Neurochemical and Behavioral Changes as Possible Predisposing Environmental Factors in Idiopathic Parkinson's Disease

  1998cites this paper
• Understanding cell death in parkinson's disease

  1998cites this paper
• Association between the gene encoding the E2 subunit of the α‐ketoglutarate dehydrogenase complex and Parkinson's disease

  1998cites this paper
• Oxidative mechanisms in nigral cell death in Parkinson's disease.

  1998cites this paper
• Secondary inhibition of 2‐ketoglutarate dehydrogenase complex by MPTP

  1998cites this paper
• Mitochondrial dysfunction in parkinson's disease

  1998cites this paper
• Cytotoxicity of 1-amino-4-phenyl-1,2,3,6-tetrahydropyridine and 1-amino-4-phenylpyridinium ion, 1-amino analogues of MPTP and MPP+, to clonal pheochromocytoma PC12 cells.

  1998cites this paper
• Cytomegalovirus infection and schizencephaly: Case reports

  1998cites this paper
• Dimethoxyphenylethylamine and tetrahydropapaverine are toxic to the nigrostriatal system.

  1997cites this paper
• Nitric oxide synthase inhibition and MPTP‐induced toxicity in the common marmoset

  1997cites this paper
• Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture.

  1997cites this paper
• Oxidative phosphorylation defects and Alzheimer's disease

  1997cites this paper
• MPTP: A Dopaminergic Neurotoxin

  1997cites this paper
• Genetic and functional changes in mitochondria associated with aging.

  1997cites this paper
• Highly Selective Neurotoxins

  1997cites this paper
• Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1996cites this paper
• Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders

  1996cites this paper
• Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.

  1996cites this paper
• Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1996cites this paper
• Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1996cites this paper
• Effect of Dopamine, Dimethoxyphenylethylamine, Papaverine, and Related Compounds on Mitochondrial Respiration and Complex I Activity

  1996cites this paper
• Up to what extent has the etiology of Parkinson^|^apos;s disease been elucidated?

  1995cites this paper
• Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.

  1995cites this paper
• Bioenergetic and oxidative stress in neurodegenerative diseases.

  1995cites this paper
• Neurotoxins and Neurodegenerative Diseases

  1995cites this paper
• Parkinson's disease: from etiology to treatment.

  1995cites this paper
• Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1995cites this paper
• An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.

  1994cites this paper
• Studies on the pathogenesis of Parkinson's disease in Japan.

  1994cites this paper
• Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.

  1994cites this paper
• Potential of Neuroprotective Therapy in Parkinson’s Disease

  1994cites this paper
• An immunohistochemical study on α‐ketoglutarate dehydrogenase complex in Parkinson's disease

  1994cites this paper
• Abnormality of the α‐ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease

  1994cites this paper
• Mechanisms of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Induced Destruction of Dopaminergic Neurons

  1994cites this paper
• Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.

  1992cites this paper
• Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

  1992cites this paper
• Mitochondrial energy crisis as a mechanism for nigral cell death

  1991cites this paper
• Electronic and Conformational Effects on the Lipophilicity of Isomers and Analogs of the Neurotoxin 1‐Methyl‐4‐phenylpyridinium (MPP+)

  1991cites this paper
• Parkinson’s Disease. From Clinical Aspects to Molecular Basis

  1991cites this paper
• Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

  1991cites this paper
• Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases

  1990influential citation
• 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.

  1990cites this paper
• Effect of the tetraphenylboron ion on the inhibition of mitochondrial respiration in synaptosomes by the 1-methyl-4-phenylpyridinium ion (MPP(+)).

  1990cites this paper
• Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease.

  1990cites this paper